Gulf International Bank (Uk) LTD Bausch Health Companies Inc. Transaction History

Gulf International Bank (Uk) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$25.04 - $30.06 $40,064 - $48,096	-1,600 Reduced 45.34%	1,929 $53,000
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $35,965 - $57,861	-1,683 Reduced 32.29%	3,529 $112,000
Q2 2020 Jul 24, 2020	BUY	$13.31 - $20.51 $16,637 - $25,637	1,250 Added 31.55%	5,212 $95,000
Q3 2019 Oct 08, 2019	SELL	$20.88 - $25.66 $40,361 - $49,600	-1,933 Reduced 32.79%	3,962 $86,000
Q2 2019 Jul 10, 2019	SELL	$20.52 - $26.45 $26,039 - $33,565	-1,269 Reduced 17.71%	5,895 $148,000
Q1 2019 Apr 18, 2019	BUY	$20.23 - $26.29 $16,184 - $21,032	800 Added 12.57%	7,164 $176,000
Q3 2018 Nov 05, 2018	BUY	$20.64 - $25.67 $131,352 - $163,363	6,364 New	6,364 $163,000

273

252M

5.12M

9.43M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $1.84B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.